Cancer Industry News & Blogs

Industry News & Blogs

Healed of cancer – thanks to a Mammogram | PRLog
www.prlog.org | 12 hours 46 minutes ago
Healed of cancer – thanks to a Mammogram. Author Avril Dalziel Saunders releases stirring true story of triumph and recovery from breast cancer - Mammograms Save Lives - PR11797376

Ben Venue Laboratoriess Children Leukemia Drug May
www.biospace.com | 12 hours 50 minutes ago
A crucial medicine to treat childhood leukemia is in such short supply that hospitals across the country may exhaust their stores within the next two

10 Biotech Stocks With Big Potential Upside In 2012: Part Two - Seeking Alpha
seekingalpha.com | 14 hours 47 minutes ago
< strong > By < a href='http://seekingalpha.com/author/brian-nichols' > Brian Nichols < /a > : < /strong > < p > In < a href="http://seekingalpha.com/article/353861-10-biotech-stocks-with-100-upside-in-2012-part-one" > part one < /a < /p > < br/ > < a

Birth defects in offspring of cancer survivors investigated : The Lancet Oncology
www.thelancet.com | 15 hours 52 minutes ago
Birth defects in offspring of cancer survivors investigated. By - Talha Khan Burki

amednews: Cancer screening rates lower for Asians and Hispanics than other groups :: Feb. 10, 2012
www.ama-assn.org | Feb 10, 2012
Forty-seven percent received colorectal cancer screening in 2010 compared with 60% of whites, data show. Disparities also exist in testing for breast and cervical cancers.

UPenn sues Memorial Sloan-Kettering president for $1B over alleged stolen research -
www.fiercehealthcare.com | Feb 7, 2012
The President of Memorial Sloan-Kettering Cancer Center is facing a more than $1 billion lawsuit from the cancer center at the University of Pennsylvania--his former employer--over what the latter Read more...

MabCure, Biotech Investment Co | MabCure signs license agreement with Biotech Investment Corp |
www.pharmaasia.com | Feb 7, 2012
MabCure has signed a license agreement with Biotech Investment Corp. (Biotech), a Nevada-based biotechnology investment company. The agreement is an exclusive worldwide license to certain MabCure hybridoma clones producing antibodies against prostate cancer. In addition to the license fee paid to

PSA velocity a better cancer predictor | 6minutes
www.6minutes.com.au | Feb 3, 2012
Using PSA velocity improves the predictive capability for prostate cancer, a US study has shown.

How Does A Heart Know When It's Big Enough - 03/25/2010
www.hopkinsmedicine.org | Jan 27, 2012
A protein discovered in fruit fly eyes has brought a Johns Hopkins team closer to understanding how the human heart and other organs automatically "right size" themselves, a piece of information that may hold clues to controlling cancer.

Relatively lenient regulations regarding human subjects protections in the 1950s played an...
www.bioethicsinstitute.org | Jan 27, 2012
Relatively lenient regulations regarding human subjects protections in the 1950s played an important role in pediatric oncology being the first field of medicine in which doctors simultaneously treated patients and carried out clinical research, according to a pediatric hematologist-oncologist at